+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Not yet known side effects of pirfenidone in the treatment of idiopathic pulmonary fibrosis?



Not yet known side effects of pirfenidone in the treatment of idiopathic pulmonary fibrosis?



Revista Portuguesa de Pneumologia 22(2): 126-127




(PDF emailed within 0-6 h: $19.90)

Accession: 058427929

Download citation: RISBibTeXText

PMID: 26614448

DOI: 10.1016/j.rppnen.2015.10.002


Related references

Pirfenidone: significant treatment effects in idiopathic pulmonary fibrosis. Clinical Respiratory Journal 6(3): 131-143, 2012

Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models. Pharmaceutical Biology 55(1): 450-455, 2017

Pharmacological properties and clinical effects of the antifibrotic agent pirfenidone (Pirespa) for treatment of idiopathic pulmonary fibrosis. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 134(2): 97-104, 2009

Pirfenidone treatment of idiopathic pulmonary fibrosis. Therapeutics and Clinical Risk Management 7: 39-47, 2011

Pirfenidone for the treatment of idiopathic pulmonary fibrosis. Expert Review of Clinical Pharmacology 10(5): 483-491, 2017

Pirfenidone treatment of idiopathic pulmonary fibrosis. Therapeutic Advances in Respiratory Disease 6(2): 107-114, 2012

Idiopathic pulmonary fibrosis: treatment with pirfenidone. Archivos de Bronconeumologia 48 Suppl 2: 16-18, 2013

Pirfenidone for the treatment of idiopathic pulmonary fibrosis. Expert Opinion on Investigational Drugs 15(7): 823-828, 2006

Pirfenidone for the treatment of idiopathic pulmonary fibrosis. Expert Opinion on PharmacoTherapy 15(2): 275-281, 2014

Pirfenidone for the treatment of idiopathic pulmonary fibrosis. Expert Review of Respiratory Medicine 8(5): 539-545, 2015

The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis. Respiratory Research 14 Suppl 1: S5, 2014

Pirfenidone and Nintedanib for Treatment of Idiopathic Pulmonary Fibrosis. Southern Medical Journal 110(6): 393-398, 2017

Pirfenidone: a novel agent for the treatment of idiopathic pulmonary fibrosis. Annals of PharmacoTherapy 47(3): 361-367, 2013

Pirfenidone Initiates a New Era in the Treatment of Idiopathic Pulmonary Fibrosis. Annual Review of Medicine 67: 487-495, 2016

Intraindividual response to treatment with pirfenidone in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 191(1): 110-113, 2015